Sign in
4

Changes in Ownership

CRISPR Therapeutics AG Filed Acc 0001209191-20-032312

Executive VP, Head of R&D sold 6,700 shares at an average $70.13 ($469,884)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ho Tony W Executive VP, Head of R&D 2020-05-22 Sale −600 $70.05 $42,030 47,005 D: show line 1 in the form
Ho Tony W Executive VP, Head of R&D 2020-05-26 Sale −6,100 $70.14 $427,854 40,905 D: show line 2 in the form
Open-market sales · 6,700 sh · avg $70.13 · $469,884
Loading xslF345X03/doc4.xml…